ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV...
CEO promises 'relentless pursuit' of new treatments - - Today, ViiV Healthcare, a new specialist HIV company established by GlaxoSmithKline (GSK) and Pfizer, was officially launched. Dr Dominique Lime... [read full story]
|
RELATED
|
|
GSK and Pfizer launch ViiV Healthcare
Related topics: Globalisation, Industry Drivers GSK and Pfizer have launched their HIV focused JV, ViiV Healthcare with the promise that it will undertake “relentless pursuit” of new drugs. The joint venture (JV), which was...
ViiV vows joint venture will help fight HIV (at FT.com)
The new head of the pioneering HIV joint venture between GlaxoSmithKline and Pfizer predicts his company can operate for at least five years without fresh funding from its shareholders. Dominique Limet, chief executive of ViiV...
Related categories
Sexually Transmitted Diseases, Infections, Family, Epidemic, Transportation, Ambulatory Health Care, Scientific Discoveries, Senior Management, General Management Issues, Health Care, Research & Development, CFO, Humanitarian & Development Assistance, Anti-virals, Pharmaceuticals, Medicines & Remedies, Pipeline Transport, CEO, Children, HIV & AIDS, Medical Research, GlaxoSmithKline
- Sexually Transmitted ...
- Infections
- Family
- Epidemic
- Transportation
- Ambulatory Health Care
- Scientific Discoveries
- Senior Management
- General Management Issues
- Health Care
- Research & Development
- CFO
- Humanitarian & ...
- Anti-virals
- Pharmaceuticals
- Medicines & Remedies
- Pipeline Transport
- CEO
- Children
- HIV & AIDS
- Medical Research
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
